ACCENTIA BIOPHARMACEUTICALS INC Interest Expense
ACCENTIA BIOPHARMACEUTICALS INC reported Interest Expense of $7.91 million for the 12-month period ending 2012-09-30, per its 10-K filed 2012-12-26.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2012-12-26
- ACCENTIA BIOPHARMACEUTICALS INC interest expense for the quarter ending 2012-09-30 was $2.16M, a 21.59% increase year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC interest expense for the quarter ending 2012-06-30 was $1.90M, a 1.52% increase year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC interest expense for the quarter ending 2012-03-31 was $1.90M, a 7.66% decline year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC interest expense for the quarter ending 2011-12-31 was $1.95M, a 18.40% decline year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC interest expense for fiscal 2012 was $7.91M, a 2.29% decline from fiscal 2011.
- ACCENTIA BIOPHARMACEUTICALS INC interest expense for fiscal 2011 was $8.09M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2012-09-30 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26 | $4.06M derived: sum of 2 quarters · filed 2012-12-26 | $5.96M derived: sum of 3 quarters · filed 2012-12-26 | $7.91M 10-K · filed 2012-12-26 |
| 2012-06-30 | $1.90M 10-Q · filed 2012-08-14 | $3.79M derived: sum of 2 quarters · filed 2012-08-14 | $5.75M 10-Q · filed 2012-08-14 | $7.52M derived: sum of 4 quarters · filed 2012-12-26 |
| 2012-03-31 | $1.90M 10-Q · filed 2012-05-15 | $3.85M 10-Q · filed 2012-05-15 | $5.63M derived: sum of 3 quarters · filed 2012-12-26 | $7.50M derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-12-31 | $1.95M 10-Q · filed 2012-02-10 | $3.73M derived: sum of 2 quarters · filed 2012-12-26 | $5.60M derived: sum of 3 quarters · filed 2012-12-26 | $7.65M derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-09-30 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26 | $3.65M derived: sum of 2 quarters · filed 2012-12-26 | $5.70M derived: sum of 3 quarters · filed 2012-12-26 | $8.09M 10-K · filed 2012-12-26 |
| 2011-06-30 | $1.87M 10-Q · filed 2012-08-14 | $3.92M derived: sum of 2 quarters · filed 2012-08-14 | $6.32M 10-Q · filed 2012-08-14 | |
| 2011-03-31 | $2.06M 10-Q · filed 2012-05-15 | $4.45M 10-Q · filed 2012-05-15 | ||
| 2010-12-31 | $2.39M 10-Q · filed 2012-02-10 |